Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma

European Journal of Endocrinology

Volumn 162, Issue 5, 2010, Pages 1001-1008

  Ong, Gregory S Y ^a   Henley, David E ^b   Hurley, David ^c   Turner, J Harvey ^d   Claringbold, Phillip G ^a   Fegan, P Gerry ^a  

^a Fremantle Hospital and Health Service   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CAPECITABINE; CARBOHYDRATE; CHLORHEXIDINE; DIAZOXIDE; EVEROLIMUS; GLUCOSE; INSULIN; OCTREOTATE LU 177; OCTREOTIDE; PENTETREOTIDE IN 111; PREDNISOLONE; SOMATOSTATIN DERIVATIVE; SPIRONOLACTONE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; EVENING DOSAGE; FLUID RETENTION; FOLLICULITIS; HERPES SIMPLEX; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULINOMA; LEUKOPENIA; LIVER METASTASIS; MALE; MORNING DOSAGE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SIDE EFFECT; TUMOR VOLUME;

AGED; HUMANS; HYPOGLYCEMIA; INSULINOMA; LIVER NEOPLASMS; MALE; MIDDLE AGED; OCTREOTIDE; ORGANOMETALLIC COMPOUNDS; PANCREATIC NEOPLASMS; RADIOPHARMACEUTICALS; SIROLIMUS;

EID: 77951654565     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-1010     Document Type: Article

References (31)

1. Abood GJ, Go A, Malhotra D & Shoup M. The surgical and systemic management of neuroendocrine tumors of the pancreas. Surgical Clinics of North America 2009 89 249-266.
2. Goldin SB, Aston J & Wahi MM. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature. Current Opinion in Oncology 2008 20 25-33. (Pubitemid 350190978)
3. Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B, Buscail L, Susini C & Caron P. Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. European Journal of Endocrinology 2005 152 757-767. (Pubitemid 40744545)
4. Vezzosi D, Bennet A, Courbon F & Caron P. Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism. Clinical Endocrinology 2008 68 904-911. (Pubitemid 351703950)
5. Usukura M, Yoneda T, Oda N, Yamamoto Y, Takata H, Hasatani K & Takeda Y. Medical treatment of benign insulinoma using octreotide LAR: a case report. Endocrine Journal 2007 54 95-101. (Pubitemid 46481677)
6. Novotny J, Janku F, Mares P & Petruzelka L. Symptomatic control of hypoglycaemia with prednisolone in refractory metastatic pancreatic insulinoma. Supportive Care in Cancer 2005 15 700-702. (Pubitemid 41435569)
7. Kaltsas GA, Besser M & Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocrine Reviews 2004 26 468-511.
8. Rinke A, Müller HH, Schade-Brittinger C, Klose KJ, Barth P, Wied M, Mayer C, Aminossadati B, Pape UF, Bläker M, Harder J, Arnold C, Gress T & Arnold R. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. Journal of Clinical Oncology 2009 28 4656-4663.
9. 3]octreotate in patients with endocrine gastroenteropancreatic tumors. Journal of Clinical Oncology 2005 23 2754-2762.
10. van Essen M, Krenning EP, Kam BL, de Herder WW, van Aken MO & Kwekkeboom DJ. Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging 2008 35 743-748.
11. Crutchlow MF & Bloom RD. Transplant-associated hyperglycemia: a new look at an old problem. Clinical Journal of the American Society of Nephrology 2007 2 343-355.
12. Hulke MH, Bergsland EK & Yao JC. Glycemic control in patients with insulinoma treated with everolimus. New England Journal of Medicine 2009 360 195-197.
13. Bourcier ME, Sherrod A, Diguardo M & Vinik AI. Successful control of intractable hypoglycemia using rapamycin in an 86-year old man with a pancreatic insulin-secreting islet cell tumor and metastases. Journal of Clinical Endocrinology and Metabolism 2009 94 3157-3162.
14. Sankhala K, Mita A, Kelly K, Mahalingam D, Giles F & Mita M. The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents. Targeted Oncology 2009 4 135-142.
15. Yao JC, Phan AT, Chang DZ, Jacobs C, Mares JE, Rashid A & Meric-Bernstam F. Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma. (2006 ASCO Annual Meeting Proceedings Abstract). Journal of Clinical Oncology 2006 24 18s.
16. Yao JC, Lombard-Bohas C, Baudin E, Kvols LK, Rougier P, Ruszniewski P, Hoosen S, St Peter J, Haas T, Lebwohl D, Van Cutsem E, Kulke MH, Hobday TJ, O'Dorisio TM, Shah MH, Cadiot G, Luppi G, Posey JA & Wiedenmann B. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. Journal of Clinical Oncology 2010 28 69-76.
17. Moro JA, Almenar L, Martinez-Dolz L, Sanchez-Lazaro J, Aguero J & Salvador A. Tolerance profile of the proliferation signal inhibitors everolimus and sirolimus in heart transplantation. Transplantation Proceedings 2008 40 3034-3036.
18. Goode PN, Farndon JR, Anderson J, Johnston IDA & Morte JA. Diazoxide in the management of patients with insulinoma. World Journal of Surgery 1986 10 586-592.
19. Burr IM, Marliss EB, Stauffacher W & Renold AE. Diazoxide effects on biphasic insulin release: "adrenergic" suppression and enhancement in the perifused rat pancreas. Journal of Clinical Investigation 1971 50 1444-1450.
20. Altszuler N, Moraru E & Hampshire J. On the mechanism of diazoxide-induced hyperglycemia. Diabetes 1977 26 931-935.
21. Stefanini P, Carboni M, Patrassi N, De Bernardinis G & Negro P. Problems of the management of insulinomas. Review of 132 cases treated with medical measures. Acta Diabetologica 1974 11 71-74.
22. Gill GV, Rauf O & MacFarlane IA. Diazoxide treatment for insulinoma: a national UK survey. Postgraduate Medical Journal 1997 73 640-641. (Pubitemid 27464460)
23. Shaer AJ. Management of hyperinsulinemia with diazoxide in an elderly hemodialysis patient. Nephron 2001 89 337-339. (Pubitemid 34701768)
24. Schäcke H, Döcke W-D & Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacology and Therapeutics 2002 96 23-43. (Pubitemid 35346616)
25. Isacoff WH, Moss RA, Pecora AL & Fine RL. Temozolomide/ capecitabine therapy for metastatic neuroendocrine tumors of the pancreas. A retrospective review (2006 ASCO Annual Meeting Proceedings Abstract). Journal of Clinical Oncology 2006 24 18s.
26. Claringbold PG, Brayshaw PA, Krenning EP, Kwekkeboom DJ & Turner JH. Radiopeptide control of endocrine cancer: a phase IIa study of 177Lu-octreotate/capecitabine therapy of disseminated neuroendocrine tumours (33rd ESMO Congress 2008 Abstract). Annals of Oncology 2008 19s 167.
27. Eriksson B & Oberg K. An update of the medical treatment of malignant endocrine pancreatic tumors. Acta Oncologica 1993 32 203-208. (Pubitemid 23188537)
28. Sarmiento JM & Que FG. Hepatic surgery for metastases from neuroendocrine tumours. Surgical Oncology Clinics of North America 2003 12 231-242.
29. Brentjens R & Saltz L. Islet cell tumors of the pancreas: the Medical Oncologist's Perspective. Surgical Clinics of North America 2001 81 527-542. (Pubitemid 32612114)
30. Plöckinger U, Wiedenmann B, Biotherapy U & Plockinger B. Neuroendocrine tumors. Biotherapy. Best Practice & Research. Clinical Endocrinology & Metabolism 2007 21 145-162.
31. Healy ML, Dawson SJ, Murray RML, Zalcberg J & Jefford M. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma. Internal Medicine Journal 2007 37 406-409. (Pubitemid 47029891)